Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Galderma describes new series of vitamin D analogues for skin disorders

Jan. 7, 2003

Zindaclin receives further E.U. approvals

Jan. 7, 2003

Genentech and Xoma submit BLA for FDA approval of Raptiva

Jan. 3, 2003

Olux approved for treatment of psoriasis

Jan. 3, 2003

Phase I trial of BI-K0376 completes enrollment

Dec. 30, 2002

Phase II trial of VX-148 in psoriasis patients commences in Iceland

Dec. 27, 2002

Fujisawa expands topical Atrisone collaboration with Atrix

Dec. 27, 2002

New modulators of IL-8 and related chemokines identified by French researchers

Dec. 23, 2002

VEGFR inhibitors and their use in psoriasis and other disorders

Dec. 16, 2002

IL-15-targeting antibody superior to ciclosporin in mouse model of psoriasis

Dec. 10, 2002

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....